{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:29:55Z","timestamp":1759742995916,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12149-021-01653-0","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T09:03:14Z","timestamp":1627462994000},"page":"1157-1166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["99mTc-labelled glucosamine in the assessment of systemic sclerosis inflammatory lung disease: a novel inexpensive investigative tool with predictive value."],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2525-8927","authenticated-orcid":false,"given":"H.","family":"Englert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-8808","authenticated-orcid":false,"given":"BL.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9181-5760","authenticated-orcid":false,"given":"S.","family":"Angelides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3188-5185","authenticated-orcid":false,"given":"V.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5126-6659","authenticated-orcid":false,"given":"D.","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0160-6413","authenticated-orcid":false,"given":"G.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6525-7830","authenticated-orcid":false,"given":"N.","family":"Manolios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"issue":"7","key":"1653_CR1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis 1972\u20132002. Ann Rheum Dis. 2007;66(7):940\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1653_CR2","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bansel DF, Allanore Y, Muller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010;69(10):1809\u201315.","journal-title":"Ann Rheum Dis"},{"issue":"127","key":"1653_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1183\/09059180.00005512","volume":"229","author":"JJ Solomon","year":"2013","unstructured":"Solomon JJ, Olson AL, Fischer A, Bull T, Brown KK, Raghu G. Scleroderma lung disease. Eur Respir Rev. 2013;229(127):6\u201319.","journal-title":"Eur Respir Rev"},{"issue":"3","key":"1653_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1378\/chest.114.3.801","volume":"114","author":"EL Greidinger","year":"1998","unstructured":"Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA. African American race and antibodies to topoisomerase 1 are associated with increased severity of scleroderma lung disease. Chest. 1998;114(3):801\u20137.","journal-title":"Chest"},{"key":"1653_CR5","doi-asserted-by":"crossref","unstructured":"R Steele M Hudson E Lo M Baron Canadian Scleroderma Research Group 2012 Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis Arthritis Care Res 64 4 519 524","DOI":"10.1002\/acr.21583"},{"issue":"1","key":"1653_CR6","first-page":"81","volume":"24","author":"S Morelli","year":"1991","unstructured":"Morelli S, Barbieri C, Sgreccia A, Ferrante L, Pittoni V, Conti F, Gualdi G, Polettini E, Carlesimo OA, Calvieri S. Relationship between cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol. 1991;24(1):81\u20135.","journal-title":"J Rheumatol"},{"issue":"9","key":"1653_CR7","first-page":"1789","volume":"33","author":"D Launay","year":"2006","unstructured":"Launay D, Remy-Jardin M, Mihon-Pasturel M, Mastera I, Hachulla E, Lambert M, Delannoy V, Querrel V, Duhamel A. Matran R et al High resolution computerised tomography in fibrosing alveolitis associated with systemic sclerosis. J Rheumatol. 2006;33(9):1789\u2013801.","journal-title":"J Rheumatol"},{"key":"1653_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1378\/chest.07-2444","volume":"134","author":"JG Goldin","year":"2008","unstructured":"Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashon S, McNitt-Gray MF, Brown MS, Roth MD, Tashkin DP. Scleroderma Lung Study Research Group high resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest. 2008;134:358\u201367.","journal-title":"Chest"},{"key":"1653_CR9","doi-asserted-by":"crossref","unstructured":"D Giuggioli F Lumetti M Colaci P Fallahi A Antonelli C Ferri 2015 Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature Autoimmun Rev 14 11 1072 1078.","DOI":"10.1016\/j.autrev.2015.07.008"},{"issue":"4","key":"1653_CR10","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1186\/ar4606","volume":"16","author":"P Fraticelli","year":"2014","unstructured":"Fraticelli P, Gabrielli B, Pomponio G, Valentini G, Bosello S, Riboldi P, Gerosa M, Faggioli P, Gioconelli R, et al. Low dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study. Arthritis Res Ther. 2014;16(4):R144.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1653_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3899\/jrheum.121043","volume":"40","author":"A Fischer","year":"2013","unstructured":"Fischer A, Brown KK, Du Bois RM, Frankel AK, Cosgrove GP, Fendandez-Perez ER. Huie TJ at al Mycophenylate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol. 2013;40(5):640\u20136.","journal-title":"J Rheumatol"},{"key":"1653_CR12","doi-asserted-by":"crossref","unstructured":"PM Hassoun 2011 Lung involvement in systemic sclerosis Presse Med 40 1 Pt2 e25 e39","DOI":"10.1016\/j.lpm.2010.08.006"},{"issue":"7","key":"1653_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/01.rlu.0000222678.95218.42","volume":"31","author":"GW Goerres","year":"2006","unstructured":"Goerres GW, Forster A, Uebelhart D, et al. F-18 FDG whole-body PET for the assessment of disease activity in patients with RA. Clin Nucl Med. 2006 Jul;31(7):386\u201390.","journal-title":"Clin Nucl Med"},{"issue":"4","key":"1653_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s10067-004-1018-0","volume":"24","author":"P Gupta","year":"2005","unstructured":"Gupta P, Ponzo F, Kramer EL. Fluorodeoxyglucose (FDG) uptake in pulmonary rheumatoid nodules. Clin Rheumatol. 2005 Aug;24(4):402\u20135.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"1653_CR15","first-page":"956","volume":"45","author":"C Beckers","year":"2004","unstructured":"Beckers C, Ribbens C, Andre B, Marcelis S, Kaye O, Mathy L, Kaiser MJ, Hustinx R, Foidart J, Malaise MG. Assessment of disease activity in RA with (18)F-FDG PET. J Nucl Med. 2004 Jun;45(6):956\u201364.","journal-title":"J Nucl Med"},{"issue":"4","key":"1653_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/s10165-006-0485-3","volume":"16","author":"K Umekita","year":"2006","unstructured":"Umekita K, Takajo I, Miyauchi S, et al. (18F) fluorodeoxyglucose positron emission tomography is a useful tool to diagnose the early stage of Takayasu\u2019s arteritis and to evaluate the activity of the disease. Mod Rheumatol. 2006;16(4):243\u20137.","journal-title":"Mod Rheumatol"},{"issue":"6","key":"1653_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00259-004-1757-9","volume":"32","author":"MA Walter","year":"2005","unstructured":"Walter MA, Melzer RA, Schindler C, et al. The value of (18F) FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005 Jun;32(6):674\u201381.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl","key":"1653_CR18","first-page":"299P","volume":"44","author":"M Yukihiro","year":"2003","unstructured":"Yukihiro M, Yang DJ, Azhdarinia A, Yu D, Kim C. Assessment of tumor growth with 99mTc-EC-Glucosamine. J Nuc Med. 2003;44(Suppl):299P.","journal-title":"J Nuc Med"},{"issue":"Suppl","key":"1653_CR19","first-page":"323P","volume":"45","author":"A Azhdarinia","year":"2003","unstructured":"Azhdarinia A, Yang DJ, Yukihiro M. Imaging dosimetry and acute toxicity with 99mTc-EC-deoxyglucose in tumor-bearing animals. J Nuc Med. 2003;45(Suppl):323P.","journal-title":"J Nuc Med"},{"issue":"6","key":"1653_CR20","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/MNM.0000000000000096","volume":"35","author":"S Angelides","year":"2014","unstructured":"Angelides S, El-Mashaleh M, Anagnostou M, Howe G, Spencer D, Kumar V, Manolios N. The role of 99mTc-labelled glucosamine (99mTc-ECDG) in the evaluation of rheumatic joint disease: a screening experience. Nucl Med Commun. 2014 Jun;35(6):655\u201365.","journal-title":"Nucl Med Commun"},{"issue":"2","key":"1653_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5152\/eurjrheum.2016.15074","volume":"3","author":"N Manolios","year":"2016","unstructured":"Manolios N, Ali M, Camden B, Eflaki E, Pavic K, Markewycz A, DeCosta R, Angelides S. Evaluating disease activity in patients with ankylosing spondylitis and rheumatoid arthritis using 99mTc-glucosamine. Eur J Rheumatol. 2016 Jun;3(2):65\u201372.","journal-title":"Eur J Rheumatol"},{"issue":"10","key":"1653_CR22","first-page":"1520","volume":"18","author":"JH Warrick","year":"1991","unstructured":"Warrick JH, Bhalla M, Schabel SI, Silver RM. High resolution computed tomography in early scleroderma lung disease. J Rheumatol. 1991;18(10):1520\u20138.","journal-title":"J Rheumatol"},{"issue":"2","key":"1653_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1148\/radiol.2262011811","volume":"226","author":"DJ Yang","year":"2003","unstructured":"Yang DJ, Kim CG, Schechter NR, Azhdarinia A, Yu DF, Oh CS, Bryant JL, Won JJ, Kim EE, Podoloff DA. Imaging with 99mTc-GS Targeted at the multifunctional glucose transport system: feasibility study with rodents. Radiology. 2003;226(2):465\u201373.","journal-title":"Radiology"},{"key":"1653_CR24","doi-asserted-by":"crossref","unstructured":"MM Khalil JL\u00a0Tremoleda TB\u00a0Bayomy W\u00a0Gsell 2011 Molecular SPECT Imaging: An Overview Int J Mol Imaging\u00a01 15","DOI":"10.1155\/2011\/796025"},{"key":"1653_CR25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/rheumatology\/kez483","volume":"59","author":"DM Peelen","year":"2020","unstructured":"Peelen DM, Zwezerijnen BGJC, Nossent EJ, Meijboom LJ, Hoekstra OS, Van der Laken CJ, Voskuyl AE. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients. Rheumatology. 2020 Oct;59:1407\u201315.","journal-title":"Rheumatology"},{"key":"1653_CR26","doi-asserted-by":"crossref","unstructured":"Bellando Randone S, Tartarelli L, Cavigli E, at al. 18F-fluorodeoxyglucose positron-emission tomography\/CT and lung involvement in systemic sclerosis. Annals of the Rheumatic Diseases\u00a02019; 78:577\u2013578.","DOI":"10.1136\/annrheumdis-2018-213376"},{"key":"1653_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13075-021-02460-8","volume":"23","author":"E Ledoult","year":"2021","unstructured":"Ledoult E, Morelle M, Soussan M, M\u00e9kinian A, B\u00e9hal H, Sobanski V, Hachulla E, Huglo D, Le Gouellec N, Remy-Jardin M, Baillet C, Ledoult DL, et al. 18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study. Arthritis Res Ther. 2021;23:76\u201387.","journal-title":"Arthritis Res Ther"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01653-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-021-01653-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01653-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T18:22:30Z","timestamp":1630434150000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-021-01653-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1653"],"URL":"https:\/\/doi.org\/10.1007\/s12149-021-01653-0","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"type":"print","value":"0914-7187"},{"type":"electronic","value":"1864-6433"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"4 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nil.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}